TrianglePUBLICATIONS · 1730080
Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 1992 Jan 15
- First author
- Wiernik PH
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Wiernik PH
- type
- Author
- name
- Banks PL
- type
- Author
- name
- Case DC Jr
- type
- Author
- name
- Arlin ZA
- type
- Author
- name
- Periman PO
- type
- Author
- name
- Todd MB
- type
- Author
- name
- Ritch PS
- type
- Author
- name
- Enck RE
- type
- Author
- name
- Weitberg AB
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wiernik PH
- type
- Author
- name
- Banks PL
- type
- Author
- name
- Case DC Jr
- type
- Author
- name
- Arlin ZA
- type
- Author
- name
- Periman PO
- type
- Author
- name
- Todd MB
- type
- Author
- name
- Ritch PS
- type
- Author
- name
- Enck RE
- type
- Author
- name
- Weitberg AB
- type
- Author
- bibliography ids
- nci-bib-e91fdd9bba85edcd1c60e87e
- book metadata
- content sha256
- f19c284f5c3f793bad386d592fbcea1e3f33949b854fe79e1e0faf1c6bad8b4b
- document type
- citation
- dois
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:1730080
- immutable id
- pubmed:1730080@f19c284f5c3f793bad386d592fbcea1e3f33949b854fe79e1e0faf1c6bad8b4b
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 2
- name
- Blood
- nlm unique id
- 7603509
- pages
- 313-9
- volume
- 79
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 1730080
- provenance
- batch id
- 4dd31a34efbe4b9fe1c1
- provider
- NCBI PubMed ESummary
- record sha256
- c2389b2e8fa1c67fba75a7869601027ff0aece4b68607e9146269f0e20b5429c
- response sha256
- 6a38fb0063e4902598a1efcc0d1821501cf82821747967b29fe13940a1d400ba
- retrieved at
- 2026-09-09T23:45:07.034965+00:00
- publication date
- display
- 1992 Jan 15
- precision
- day
- year
- 1992
- publication types
- Clinical Trial
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/1730080/
- title
- Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia.
Preserved source evidence · Not medical advice